Dear Editor, Surface-exposed calreticulin (ecto-CRT) and secreted ATP have emerged as incontrovertible danger signals. [1] [2] [3] A surge in studies describing the impact of these danger signals has also spurred a tremendous interest in the discovery of signaling pathways regulating their 'emission'. Recent research has shown that the pathways regulating the emission of these danger signals exhibit a certain degree of 'plasticity' and context-dependency. [1] [2] [3] [4] This applies mainly to the pathways regulating ecto-CRT emission and ATP secretion induced by mitoxantrone (MTX) 2 and hypericinbased photodynamic therapy (Hyp-PDT). [3] [4] [5] Irrespective of the inducers though, molecular components regulating endoplasmic reticulum (ER)-stress and autophagy have been found to form the 'core' of pathways behind ecto-CRT and secreted ATP. 1, 3, 5 While ER-stress tends to regulate these pathways positively, 1,3 macroautophagy has recently emerged to play a more contextual role. 1, 6 While on one hand, macroautophagy was found to positively regulate MTX-induced ATP secretion, 2 on the other we found that macroautophagy negatively regulates Hyp-PDT-induced ecto-CRT 6 (without affecting ATP secretion 6 ). This further increased our curiosity regarding the role of autophagy pathways behind ecto-CRT/secreted ATP. Interestingly, it was recently shown that the lysosomal protein LAMP1 can regulate MTX-induced ATP secretion. 2 We have previously shown that oxidative stress generated by Hyp-PDT along with macroautophagy can stimulate chaperone-mediated autophagy (CMA), a process mediated by the lysosomal protein, LAMP2A 7, 8 Cells lacking LAMP2A were found to be extremely sensitized toward Hyp-PDT-induced apoptotic cell death, which is mediated by severe reactive oxygen species-induced ER stress. 7 On the back of these exciting results, we became curious about the impact this CMA-essential gene can have on cell-surface exposure of CRT and secretion of ATP.
To this end, we tested the ability of LAMP2A þ / þ and LAMP2A
À / À cells to emit secreted ATP/ecto-CRT following MTX/Hyp-PDT treatments. MTX and Hyp-PDT induced significant secretion of ATP in LAMP2A þ / þ cells as compared with the untreated cells (Supplementary Figure S1A) .
Similarly, the LAMP2A
À / À cells also retained their capacity to secrete ATP following MTX/Hyp-PDT treatment, to the same extent as the LAMP2A þ / þ cells (Supplementary Figure S1A) .
Next, we analyzed the induction of ecto-CRT and found both MTX and Hyp-PDT to be potent inducers of ecto-CRT in the LAMP2A þ / þ cells (Supplementary Figure S1B) , as expected. 4 ,5 Interestingly, we found that the LAMP2A
À / À cells exhibited a strong inability to emit ecto-CRT, not only following MTX/Hyp-PDT treatments but also in basal conditions (Supplementary Figure S1B) . This complete abrogation of ecto-CRT in the absence of LAMP2A indicated an 'innate' dysfunction of ecto-CRT trafficking pathway in these cells. It has been well established that cells lacking LAMP2A exhibit a compensatory rise in macroautophagy, under basal conditions, to counter the absence of CMA. 7, 8 We had recently observed that ablation of macroautophagy (via ATG5-siRNA) increased Hyp-PDT-induced ecto-CRT. 6 Thus, we wondered whether we can rescue ecto-CRT emission in LAMP2A À / À cells underlies their inability to emit ecto-CRT (rather than compensatory rise in ATG5-regulated macroautophagy) -a premise that needs to be comprehensively investigated.
In conclusion, we found that LAMP2A is dispensable for both MTX and Hyp-PDT-induced ATP secretion. However interestingly, we observed that the absence of LAMP2A abrogates ecto-CRT emission (in basal and MTX/Hyp-PDT treatment scenarios) -a dysfunction that cannot be rescued by siRNA-based knock-down of ATG5. In future, it would be imperative to investigate whether there is a direct link between ecto-CRT emission and CMA induction.
